Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PLGRKT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRUNE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DGAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THEM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB29 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ENSA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDUFS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HPF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
JADE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPL10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
POGZ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPDL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PYURF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POGK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIMM8B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELK4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BCAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SDHC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on